Health Care: Drugs

Titan Pharmaceuticals Inc (TTNP: OTC)

$0.65 n/a | n/a%
08/29/14 - 03:37 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 9.71M -15.18M -15.20M -6.83M
Operating Gains/Losses -10.82M 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -172.00K -926.00K -2.50M -1.16M
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 1.35M -1.02M 2.33M 2.12M
(Decrease) Increase In Other Current Liabilities -340.00K 417.00K -744.00K 308.00K
(Increase) Decrease In Other Working Capital -9.06M 14.38M 0.00 0.00
Other Non-Cash Items -1.06M 4.00M 624.00K 865.00K
Net Cash From Continuing Operations -9.80M 1.83M -14.48M -4.66M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -9.80M 1.83M -14.48M -4.66M
Sale of Property, Plant & Equipment 0.00 0.00 2.00K 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -318.00K -1.15M -236.00K -28.00K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -318.00K -1.15M -234.00K -28.00K
Issuance of Debt 0.00 0.00 16.50M 5.00M
Cash Used for Financing Activities
Issuance of Capital Stock 6.31M 12.41M 0.00 0.00
Repayment of Long-Term Debt -2.50M -393.00K -7.56M -435.00K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 8.00M 0.00
Net Cash From Financing Activities 3.81M 12.02M 16.94M 4.56M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -6.30M 12.70M 2.23M -120.00K
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter